
USA - NASDAQ:CHFS -
The current stock price of CHFS is 5.28 null. In the past month the price decreased by -10.58%. In the past year, price decreased by -57.78%.
CHF Solutions, Inc. is a medical device company which focused on commercializing the Aquadex FlexFlow (R) System. Its commercial product Aquadex system, is indicated for temporary ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. CHF Solutions Inc., formerly known as Sunshine Heart Inc., is headquartered in Minneapolis.
CHF Solutions Inc
12988 VALLEY VIEW ROAD
EDEN PRAIRIE MN 55344
CEO: Nestor Jaramillo
Phone: 952-345-4200
CHF Solutions, Inc. is a medical device company which focused on commercializing the Aquadex FlexFlow (R) System. Its commercial product Aquadex system, is indicated for temporary ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. CHF Solutions Inc., formerly known as Sunshine Heart Inc., is headquartered in Minneapolis.
The current stock price of CHFS is 5.28 null. The price increased by 1.15% in the last trading session.
CHFS does not pay a dividend.
CHFS has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
CHF Solutions Inc (CHFS) has a market capitalization of 31.88M null. This makes CHFS a Nano Cap stock.
ChartMill assigns a fundamental rating of 3 / 10 to CHFS. The financial health of CHFS is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months CHFS reported a non-GAAP Earnings per Share(EPS) of -10.67. The EPS increased by 96.18% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -212.82% | ||
| ROA | -79.13% | ||
| ROE | N/A | ||
| Debt/Equity | 0 |